Sharekhan

BUY NOW Buy Shukra Pharmaceuticals Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Shukra Pharmaceuticals Ltd

Fri 9/01/2026,16:1:0

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Shukra Pharmaceuticals Ltd

Your Vote -

Buy

58.33%

Hold

16.67%

Sell

25.00%

58.33%

12 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Shukra Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Shukra Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jan 2026, 1:55PM Certificate under Regulation 74(5) of SEBI ( Depositories and Participants ) for the quarter ended December 31, 2025.

  • Shukra Pharma - Voting Result Along With Scrutinizer Report Of Postal Ballot

    5 Jan 2026, 7:42PM As attached

  • Shukra Pharma - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    5 Jan 2026, 3:14PM Intimation pertaining to Memorandum of Understanding (\MoU\) with Borns Medical Robotics Inc., USA.

  • Shukra Pharma - Reconstitution Of Committees Of The Company.

    30 Dec 2025, 7:21PM As attached.

  • Shukra Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    30 Dec 2025, 7:20PM Appointment of Mr. Dinesh Chauhan as additional independent director of the company.

  • Shukra Pharma - Announcement under Regulation 30 (LODR)-Resignation of Director

    30 Dec 2025, 7:18PM Resignation of Ms. Bhoomi Patel from the post of Independent director as attached.

  • Shukra Pharma - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On December 30, 2025.

    30 Dec 2025, 7:16PM As attached.

  • Shukra Pharma - Intimation For Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations, Working In The Governme

    22 Dec 2025, 12:20PM Sell the Laparoscopic Sets and accessories in the Government market of Gujarat.

  • Shukra Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    3 Dec 2025, 3:17PM Receipt of Letter of Authorization from Integra Medical Devices India Private Limited.

  • Shukra Pharma - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    3 Dec 2025, 2:26PM Notice of Meeting of members by way of postal ballot commencing from December 04, 2025 to January 03, 2026.

  • Shukra Pharma - Approval Of Continuation Of Directorship Of Mr. Jitendra Somchand Shah Non-Executive Independent Director Who

    29 Nov 2025, 7:04PM As attached

  • Shukra Pharma - Outcome Of The Meeting Of The Board Of Directors Held On Saturday, November 29, 2025

    29 Nov 2025, 6:48PM Regulation 30 of the Securities and Exchange Board of India ( Listing Obligation and Disclosure Requirement ) Regulation, 2015

  • Shukra Pharma - Board Meeting Outcome for Outcome Of The Meetins Of The Board Of Directors Held On Saturdav. November\r\n29.2

    29 Nov 2025, 6:44PM Regulation 30 the Securities and Exchange Board of India ( Listing Obligation and Disclosure Requirement ) Regulation, 2015.

  • Shukra Pharma - Voting Result Along With Scrutinizer Report Of Extra Ordinary General Meeting (EOGM) Of The Company Held On N

    1 Nov 2025, 6:49PM As attached.

  • Shukra Pharma Q2 net profit zooms 340.74% at Rs 2.38 cr

    13 Nov 2025, 6:24PM The company reported standalone net profit of Rs 2.38 crore for the quarter ended September 30, 2025 as compared to Rs 0.54 crore in the same period l

  • Shukra Pharma - Un-Audited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30, 2025, Al

    13 Nov 2025, 6:16PM As attached.

  • Shukra Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On November 13, 2025.

    13 Nov 2025, 6:14PM Un-Audited Financial Results of the Company for the Second Quarter and Half Year ended September 30, 2025, along with the Auditors' Limited Review Rep

  • Shukra Pharma - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 -

    10 Nov 2025, 3:04PM Incorporation of subsidiary company.

  • Shukra Pharma - Shareholder Meeting / Postal Ballot-Outcome of EGM

    1 Nov 2025, 3:55PM Proceeding of EOGM of the company.

  • Shukra Pharma - Board Meeting Intimation for Unaudited Financial Result For The Half Year Ended On 30TH September, 2025 Along

    31 Oct 2025, 7:00PM Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consid

  • Shukra Pharma - Receipt Of Distributorship Rights

    31 Oct 2025, 6:52PM Company has received distributionship rights.

  • Shukra Pharma - Intimation U/R 30 Of SEBI LODR- Incorporation Of Subsidiary Company

    24 Oct 2025, 7:35PM Incorporation of Subsidiary Company in India under the name \Shukra Helthtech Private Limited\

  • Shukra Pharma has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    18 Oct 2025, 7:00PM As of September 2025, 50.95% is owned by Indian Promoters and 49.04% by Public. <p align=justify> Top five Promoters holding highest number of shares
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Shukra Pharmaceuticals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 67.0125 60.7935 30.3783 19.7265 25.3697
Liabilities 67.0125 60.7935 30.3783 19.7265 25.3697
Equity 43.7879 10.947 3.9142 1.5657 1.5656
Gross Profit 12.7297 19.4033 5.3633 2.8857 1.4438
Net Profit 9.5751 18.5372 4.4065 0.7507 0.0338
Cash From Operating Activities 7.9184 -5.1967 3.1695 7.7843 0.3715
NPM(%) 29.38 24.85 7.48 3.66 0.3
Revenue 32.5873 74.5729 58.8337 20.486 11.196
Expenses 19.8576 55.1696 53.4704 17.6003 9.7521
ROE(%) 14.55 28.16 6.69 1.14 0.05

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Shukra Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 744.00 -0.27 0.00 27.00 301.39 0.68
Lotus Eye Hospital and Institute Ltd 113.60 -4.98 348.69 98.37 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 18.68 -3.51 0.00 204.24 -39.50 0.00
Astec Lifesciences Ltd 639.60 -3.63 0.00 92.76 -604.77 0.00

Company Info

1998 - Mrs. Riddhi M Patel, director of the company retires by rotation as per Provisions of the Act at this Annual General Meeting. 1999 - In accordance with the Companies Act, 1956 and Articles of Association of the Company, Mr. Mihir M Patel retire by rotation and is eligible for re-appointment. - Company has installed modern energy efficient machines. 2023 -Company issued rights shares of Rs. 10 in the ratio of 6:1 at a premium of Rs. 10 per share. 2024 -The Company has issued Bonus Shares in the Ratio of 3:1.

1998 - Mrs. Riddhi M Patel, director of the company retires by rotation as per Provisions of the Act at this Annual General Meeting. 1999 - In accordance with the Companies Act, 1956 and Articles of Association of the Company, Mr. Mihir M Patel retire by rotation and is eligible for re-appointment. - Company has installed modern energy efficient machines. 2023 -Company issued rights shares of Rs. 10 in the ratio of 6:1 at a premium of Rs. 10 per share. 2024 -The Company has issued Bonus Shares in the Ratio of 3:1.

Read More

Parent Organisation

Shukra Pharmaceuticals Ltd.

Founded

04/03/1993

Managing Director

Mr.Dakshesh Rameshchandra Shah

NSE Symbol

FAQ

The current price of Shukra Pharmaceuticals Ltd is

The 52-week high for Shukra Pharmaceuticals Ltd is

The market capitalization of Shukra Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Shukra Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Shukra Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Shukra Pharmaceuticals Ltd shares.

The CEO of Shukra Pharmaceuticals Ltd is Mr.Dakshesh Rameshchandra Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT